{"id":2807,"date":"2024-07-23T20:52:36","date_gmt":"2024-07-23T20:52:36","guid":{"rendered":"https:\/\/clinicaltrials.sambrownprojects.com\/clinical-studies\/investigacion-de-una-opcion-de-tratamiento-en-fase-de-investigacion-para-la-epilepsia-generalizada-idiopatica\/"},"modified":"2025-08-11T13:36:32","modified_gmt":"2025-08-11T13:36:32","slug":"researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy","status":"publish","type":"clinical-studies","link":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/","title":{"rendered":"Investigaci\u00f3n de una opci\u00f3n de tratamiento en fase de investigaci\u00f3n para la epilepsia generalizada idiop\u00e1tica"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row wrap_container=\u00bbyes\u00bb conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb el_class=\u00bbhome-main-video bg-steady\u00bb][vc_column width=\u00bb1\/2&#8243; conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb][vc_row_inner equal_height=\u00bbyes\u00bb content_placement=\u00bbmiddle\u00bb][vc_column_inner el_class=\u00bbsma-col-left\u00bb width=\u00bb2\/6&#8243;][vc_single_image image=\u00bb2524&#8243; img_size=\u00bbfull\u00bb][\/vc_column_inner][vc_column_inner el_class=\u00bbres-text sma-col-right\u00bb width=\u00bb4\/6&#8243;][vc_column_text el_class=\u00bbstudy-type-heading\u00bb]<\/p>\n<h1>Estudio sobre la epilepsia generalizada<\/h1>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_single_image image=\u00bb2447&#8243; img_size=\u00bbfull\u00bb el_class=\u00bbimg-mobile\u00bb][vc_column_text el_class=\u00bbclinical-study-heading\u00bb]Investigaci\u00f3n para encontrar una opci\u00f3n de tratamiento para la <b>epilepsia generalizada<\/b> idiop\u00e1tica[\/vc_column_text][vc_column_text el_class=\u00bbpurpose-of-study-para\u00bb]<p><strong>\u00bfVive con epilepsia?<\/strong><\/p>\n<p>Si le han diagnosticado epilepsia generalizada y sigue teniendo crisis t\u00f3nico-cl\u00f3nicas a pesar de tomar medicamentos anticonvulsivos, es posible que nuestro ensayo cl\u00ednico pueda ayudarlo. Estamos estudiando un medicamento en fase de investigaci\u00f3n para incluirlo en sus tratamientos actuales contra la epilepsia. Participar no tiene ning\u00fan costo para usted y no se requiere un seguro.<\/p>\n[\/vc_column_text][vc_row_inner][vc_column_inner]<div class=\"porto-btn-ctn-left btn-blue btn-global\"><a class=\"porto-btn  vc_custom_1730200679657 porto-adjust-bottom-margin porto-btn-normal porto-btn-no-hover-bg   wpb_custom_fa51088c2567b780100c1edcf8821d3b  porto-btn-left \" title='Epilepsy Study Learn More' rel='' href = \"\/es\/study-resources\/shine-what-to-expect\/\"  data-hover=\"\" data-border-color=\"\" data-bg=\"\" data-hover-bg=\"\" data-border-hover=\"\" data-shadow-click=\"none\" data-shadow=\"\" style=\"border:none;color: #ffffff;\"><span class=\"porto-btn-hover\"><\/span><span class=\"porto-btn-data porto-btn-text \" >SABER M\u00c1S<\/span><\/a><\/div>[\/vc_column_inner][\/vc_row_inner][vc_column_text css=\u00bb.vc_custom_1729159460536{margin-bottom: 0px !important;}\u00bb el_class=\u00bblang-switch\u00bb]<strong>\n<div\n\t role=\"navigation\" aria-label=\"Selector de idioma\" class=\"wpml-ls-statics-shortcode_actions wpml-ls wpml-ls-legacy-dropdown js-wpml-ls-legacy-dropdown\">\n\t<ul>\n\t\t<li class=\"wpml-ls-slot-shortcode_actions wpml-ls-item wpml-ls-item-es wpml-ls-current-language wpml-ls-item-legacy-dropdown\">\n\t\t\t<a href=\"#\" hreflang=\"\" lang=\"\" class=\"js-wpml-ls-item-toggle wpml-ls-item-toggle\" aria-current=\"page\" aria-expanded=\"false\" aria-controls=\"wpml-ls-submenu-default\" aria-label=\"Selector de idioma, pulse tab para navegar a otros idiomas\" title=\"Cambiar a Espa\u00f1ol (Espa\u00f1ol)\">\n\t\t\t\t<span class=\"wpml-ls-native\">Espa\u00f1ol<\/span><\/a>\n\n\t\t\t<ul id=\"wpml-ls-submenu-default\" class=\"wpml-ls-sub-menu\">\n\t\t\t\t\n\t\t\t\t\t<li class=\"wpml-ls-slot-shortcode_actions wpml-ls-item wpml-ls-item-en wpml-ls-first-item\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.biohavenclinicaltrials.com\/\" hreflang=\"en\" lang=\"en\" class=\"wpml-ls-link\" aria-label=\"Cambiar a Ingl\u00e9s (English)\" title=\"Cambiar a Ingl\u00e9s (English)\">\n\t\t\t\t\t\t\t<span class=\"wpml-ls-native\">English<\/span><span class=\"wpml-ls-display\"><span class=\"wpml-ls-bracket\">(<\/span>Ingl\u00e9s<span class=\"wpml-ls-bracket\">)<\/span><\/span><\/a>\n\t\t\t\t\t<\/li>\n\n\t\t\t\t\n\t\t\t\t\t<li class=\"wpml-ls-slot-shortcode_actions wpml-ls-item wpml-ls-item-en-GB\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.biohavenclinicaltrials.com\/en-GB\/\" hreflang=\"en-GB\" lang=\"en-GB\" class=\"wpml-ls-link\" aria-label=\"Cambiar a Great Briton (English)\" title=\"Cambiar a Great Briton (English)\">\n\t\t\t\t\t\t\t<span class=\"wpml-ls-native\">English<\/span><span class=\"wpml-ls-display\"><span class=\"wpml-ls-bracket\">(<\/span>Great Briton<span class=\"wpml-ls-bracket\">)<\/span><\/span><\/a>\n\t\t\t\t\t<\/li>\n\n\t\t\t\t\n\t\t\t\t\t<li class=\"wpml-ls-slot-shortcode_actions wpml-ls-item wpml-ls-item-it\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.biohavenclinicaltrials.com\/it\/\" hreflang=\"it\" lang=\"it\" class=\"wpml-ls-link\" aria-label=\"Cambiar a Italiano (Italiano)\" title=\"Cambiar a Italiano (Italiano)\">\n\t\t\t\t\t\t\t<span class=\"wpml-ls-native\">Italiano<\/span><\/a>\n\t\t\t\t\t<\/li>\n\n\t\t\t\t\n\t\t\t\t\t<li class=\"wpml-ls-slot-shortcode_actions wpml-ls-item wpml-ls-item-es-AR\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.biohavenclinicaltrials.com\/es-AR\/\" hreflang=\"es-AR\" lang=\"es-AR\" class=\"wpml-ls-link\" aria-label=\"Cambiar a AR_Espa\u00f1ol (Spanish AR)\" title=\"Cambiar a AR_Espa\u00f1ol (Spanish AR)\">\n\t\t\t\t\t\t\t<span class=\"wpml-ls-native\">Spanish AR<\/span><span class=\"wpml-ls-display\"><span class=\"wpml-ls-bracket\">(<\/span>AR_Espa\u00f1ol<span class=\"wpml-ls-bracket\">)<\/span><\/span><\/a>\n\t\t\t\t\t<\/li>\n\n\t\t\t\t\n\t\t\t\t\t<li class=\"wpml-ls-slot-shortcode_actions wpml-ls-item wpml-ls-item-es-CL\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.biohavenclinicaltrials.com\/es-CL\/\" hreflang=\"es-CL\" lang=\"es-CL\" class=\"wpml-ls-link\" aria-label=\"Cambiar a CL_Espa\u00f1ol (Spanish CL)\" title=\"Cambiar a CL_Espa\u00f1ol (Spanish CL)\">\n\t\t\t\t\t\t\t<span class=\"wpml-ls-native\">Spanish CL<\/span><span class=\"wpml-ls-display\"><span class=\"wpml-ls-bracket\">(<\/span>CL_Espa\u00f1ol<span class=\"wpml-ls-bracket\">)<\/span><\/span><\/a>\n\t\t\t\t\t<\/li>\n\n\t\t\t\t\n\t\t\t\t\t<li class=\"wpml-ls-slot-shortcode_actions wpml-ls-item wpml-ls-item-pl\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.biohavenclinicaltrials.com\/pl\/\" hreflang=\"pl\" lang=\"pl\" class=\"wpml-ls-link\" aria-label=\"Cambiar a Polaco (Polski)\" title=\"Cambiar a Polaco (Polski)\">\n\t\t\t\t\t\t\t<span class=\"wpml-ls-native\">Polski<\/span><span class=\"wpml-ls-display\"><span class=\"wpml-ls-bracket\">(<\/span>Polaco<span class=\"wpml-ls-bracket\">)<\/span><\/span><\/a>\n\t\t\t\t\t<\/li>\n\n\t\t\t\t\n\t\t\t\t\t<li class=\"wpml-ls-slot-shortcode_actions wpml-ls-item wpml-ls-item-es-SP wpml-ls-last-item\">\n\t\t\t\t\t\t<a href=\"https:\/\/www.biohavenclinicaltrials.com\/es-SP\/\" hreflang=\"es-SP\" lang=\"es-SP\" class=\"wpml-ls-link\" aria-label=\"Cambiar a Espa\u00f1ol SP (Espa\u00f1ol SP)\" title=\"Cambiar a Espa\u00f1ol SP (Espa\u00f1ol SP)\">\n\t\t\t\t\t\t\t<span class=\"wpml-ls-native\">Espa\u00f1ol SP<\/span><\/a>\n\t\t\t\t\t<\/li>\n\n\t\t\t\t\t\t\t<\/ul>\n\n\t\t<\/li>\n\n\t<\/ul>\n<\/div>\n<\/strong>[\/vc_column_text][\/vc_column][vc_column width=\u00bb1\/2&#8243; text_align=\u00bbright\u00bb conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb el_class=\u00bbcol-right-study\u00bb][vc_row_inner][vc_column_inner el_class=\u00bbsocial-share-icons\u00bb][vc_single_image image=\u00bb842&#8243; onclick=\u00bbcustom_link\u00bb img_link_target=\u00bb_blank\u00bb el_class=\u00bbsocial-share-icons fb\u00bb link=\u00bbhttps:\/\/www.facebook.com\/sharer.php?u=https:\/\/www.biohavenclinicaltrials.com\/clinical-studies\/epilepsy-study\/\u00bb][vc_single_image image=\u00bb1407&#8243; onclick=\u00bbcustom_link\u00bb img_link_target=\u00bb_blank\u00bb el_class=\u00bbsocial-share-icons twitter\u00bb link=\u00bbhttps:\/\/twitter.com\/intent\/tweet?text=Rise,+A+Clinical+Trial+for+Epilepsy+l+Biohaven%29&amp;url=https:\/\/www.biohavenclinicaltrials.com\/clinical-studies\/major-depressive-disorder\/\u00bb][vc_single_image image=\u00bb1091&#8243; onclick=\u00bbcustom_link\u00bb img_link_target=\u00bb_blank\u00bb css=\u00bb.vc_custom_1698687328280{padding-top: 0px !important;}\u00bb el_class=\u00bbsocial-share-icons vimeo\u00bb link=\u00bbhttps:\/\/www.linkedin.com\/sharing\/share-offsite\/?url=https:\/\/www.biohavenclinicaltrials.com\/clinical-studies\/epilepsy-study\/\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner el_class=\u00bbsocial-share-icons1&#8243; css=\u00bb.vc_custom_1723210860946{padding-top: 0px !important;padding-right: 0px !important;padding-bottom: 0px !important;padding-left: 0px !important;}\u00bb][vc_single_image image=\u00bb2447&#8243; img_size=\u00bbfull\u00bb alignment=\u00bbright\u00bb el_class=\u00bbstudy-img-patient\u00bb][\/vc_column_inner][\/vc_row_inner][vc_row_inner content_placement=\u00bbmiddle\u00bb el_class=\u00bbshine-study-callout\u00bb][vc_column_inner el_class=\u00bbsocial-share-icons1&#8243; width=\u00bb1\/2&#8243; offset=\u00bbvc_col-sm-offset-0&#8243;][vc_single_image image=\u00bb2528&#8243; img_size=\u00bb\u00bb alignment=\u00bbright\u00bb el_class=\u00bbcallout-logo\u00bb][\/vc_column_inner][vc_column_inner width=\u00bb1\/2&#8243;][vc_column_text css=\u00bb.vc_custom_1723651578497{margin-bottom: 0px !important;}\u00bb el_class=\u00bbstudy-header-callout-text1&#8243;]<\/p>\n<p style=\"text-align: left;\">VIVIR CON<\/p>\n<p>[\/vc_column_text][vc_column_text css=\u00bb.vc_custom_1723717712259{margin-bottom: 0px !important;}\u00bb el_class=\u00bbstudy-header-callout-text2&#8243;]<\/p>\n<p style=\"text-align: left;\">FOCAL<\/p>\n<p>[\/vc_column_text][vc_column_text css=\u00bb.vc_custom_1723651611561{margin-bottom: 10px !important;}\u00bb el_class=\u00bbstudy-header-callout-text3&#8243;]<\/p>\n<p style=\"text-align: left;\">\u00bfEPILEPSIA?<\/p>\n<p>[\/vc_column_text]<div class=\"porto-btn-ctn-center btn-light-blue btn-global btn-cta\"><a class=\"porto-btn porto-adjust-bottom-margin porto-btn-normal porto-btn-no-hover-bg   wpb_custom_fa51088c2567b780100c1edcf8821d3b  porto-btn-center \"  rel='' href = \"\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-focal-onset-epilepsy\/\"  data-hover=\"\" data-border-color=\"\" data-bg=\"#e0e0e0\" data-hover-bg=\"\" data-border-hover=\"\" data-shadow-click=\"none\" data-shadow=\"\" style=\"border:none;background: #e0e0e0;color: #000000;\"><span class=\"porto-btn-hover\"><\/span><span class=\"porto-btn-data porto-btn-text \" >Haz clic aqu\u00ed<\/span><\/a><\/div>[\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row wrap_container=\u00bbyes\u00bb conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb el_class=\u00bbsubpage-nav hide-mobile ocd-study-nav\u00bb][vc_column]<div class=\"widget_sidebar_menu main-sidebar-menu wpb_custom_bd96d282bd99227adaa2fd2727fa1ab3\"><div class=\"sidebar-menu-wrap\"><ul id=\"menu-spanish-shine-study-menu\" class=\"sidebar-menu\"><li id=\"nav-menu-item-2831\" class=\"menu-item menu-item-type-post_type menu-item-object-clinical-studies  narrow \"><a href=\"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/\">Estudio sobre la epilepsia<\/a><\/li>\n<li id=\"nav-menu-item-2837\" class=\"menu-item menu-item-type-post_type menu-item-object-study-resources  narrow \"><a href=\"https:\/\/www.biohavenclinicaltrials.com\/es\/study-resources\/epilepsy-study-medication\/\">Medicamento en estudio<\/a><\/li>\n<li id=\"nav-menu-item-2836\" class=\"menu-item menu-item-type-post_type menu-item-object-study-resources  narrow \"><a href=\"https:\/\/www.biohavenclinicaltrials.com\/es\/study-resources\/shine-what-to-expect\/\">Qu\u00e9 se puede esperar<\/a><\/li>\n<li id=\"nav-menu-item-2838\" class=\"menu-item menu-item-type-post_type menu-item-object-study-resources  narrow \"><a href=\"https:\/\/www.biohavenclinicaltrials.com\/es\/study-resources\/epilepsy-study-learn-more\/\">Compruebe si re\u00fane los requisitos para participar<\/a><\/li>\n<\/ul><\/div><\/div>[\/vc_column][\/vc_row][vc_row wrap_container=\u00bbyes\u00bb conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb el_class=\u00bbinfo-middle\u00bb][vc_column][vc_column_text]<\/p>\n<h2>\u00bfQu\u00e9 es la epilepsia generalizada idiop\u00e1tica?<\/h2>\n<p>La epilepsia generalizada idiop\u00e1tica es un tipo de epilepsia que afecta a todo el cerebro y suele ser de causas desconocidas.<br \/>\nLas personas que la padecen sufren crisis que aparecen de repente y afectan a ambos lados del cerebro a la vez.<\/p>\n<p>A pesar de las terapias actuales, existe una gran necesidad insatisfecha de una mayor reducci\u00f3n de las convulsiones con menos efectos secundarios, para las personas que siguen sufriendo convulsiones mientras toman los medicamentos anticonvulsivos disponibles actualmente. Aproximadamente el 33% de los adultos pertenecen a este grupo.<\/p>\n<p>Biohaven est\u00e1 trabajando con epilept\u00f3logos y neur\u00f3logos de todo el pa\u00eds para investigar un medicamento en fase de investigaci\u00f3n que podr\u00eda ayudar a liberar de las convulsiones con menos efectos secundarios.<\/p>\n<h2>\u00bfA qui\u00e9n va dirigido el estudio?<\/h2>\n<p>Si a ti o a un ser querido os han diagnosticado epilepsia generalizada idiop\u00e1tica, ten\u00e9is entre 18 y 75 a\u00f1os y segu\u00eds sufriendo convulsiones t\u00f3nico-cl\u00f3nicas mientras tom\u00e1is uno o m\u00e1s medicamentos anticonvulsivos, puede que cumpl\u00e1is los requisitos para participar en el estudio Shine.<\/p>\n<p>Hemos llamado a este estudio \u00abBrilla\u00bb porque creemos que la epilepsia no debe impedirte vivir la vida brillante y resplandeciente de tus sue\u00f1os.<\/p>\n<p>Shine es un estudio para evaluar la eficacia, seguridad y tolerabilidad de BHV-7000 en pacientes con epilepsia generalizada idiop\u00e1tica.<\/p>\n<p>Estudio de fase 2\/3, multic\u00e9ntrico, aleatorizado, doble ciego, controlado con placebo, para evaluar la eficacia, seguridad y tolerabilidad de BHV-7000 en sujetos con epilepsia generalizada idiop\u00e1tica.[\/vc_column_text][\/vc_column][\/vc_row][vc_row wrap_container=\u00bbyes\u00bb conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb el_class=\u00bbpart-row\u00bb][vc_column width=\u00bb1\/2&#8243;]<style>.porto-info-listb35750130e0326da6c993f98c54aaf98 i { color: #73c64c;font-size: 30px; }<\/style><ul class=\"porto-info-list heading-with-icon porto-info-listb35750130e0326da6c993f98c54aaf98 wpb_custom_28094ea11f6e73822b9aaa2ab90753f4\"><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><i class=\"porto-info-icon fas fa-check\"><\/i><div class=\"porto-info-list-item-desc\">\n<h4>Los pacientes deben:<\/h4>\n<p><\/div><\/li><\/ul>[vc_column_text el_class=\u00bbparticipant-must-text\u00bb]<\/p>\n<ul>\n<li style=\"text-align: left;\">Tener entre 18 y 75 a\u00f1os.<\/li>\n<li>Haber fracasado con al menos 2 medicamentos anticonvulsivos y estar tomando actualmente una dosis estable de al menos 1 a 3 medicamentos anticonvulsivos.<\/li>\n<li>Tener un diagn\u00f3stico de epilepsia generalizada idiop\u00e1tica (EGI) durante al menos 6 meses, con confirmaci\u00f3n de crisis t\u00f3nico-cl\u00f3nicas generalizadas (CTG) -antes llamadas crisis gran-mal-.<\/li>\n<li>Haber experimentado al menos 3 d\u00edas con convulsiones GTC en los 4 meses anteriores al cribado.<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][vc_column width=\u00bb1\/2&#8243;]<style>.porto-info-list96f6db2317c2841e1076d48dd8fea25e i { color: #c52828;font-size: 30px; }<\/style><ul class=\"porto-info-list heading-with-icon porto-info-list96f6db2317c2841e1076d48dd8fea25e wpb_custom_2665cd3fd3b7047d8470fb6cc4787d59\"><li class=\"porto-info-list-item  wpb_custom_eade0171093a7591372ccf9372738e3d\"><div class=\"porto-info-list-item-desc\">\n<h4>Los pacientes lo reciben sin coste alguno:<\/h4>\n<p><\/div><\/li><\/ul>[vc_column_text el_class=\u00bbparticipant-must-not-text\u00bb]<\/p>\n<ul>\n<li style=\"text-align: left;\">El medicamento en investigaci\u00f3n o un placebo<\/li>\n<li>Todos los cuidados, pruebas y controles de tu salud relacionados con el estudio<\/li>\n<li>Acceso continuo a profesionales m\u00e9dicos que pueden responder a tus preguntas<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row wrap_container=\u00bbyes\u00bb conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb css=\u00bb.vc_custom_1683711550808{background-color: #f7f7f7 !important;}\u00bb el_class=\u00bbsection-faq\u00bb][vc_column][vc_row_inner el_class=\u00bbinner-faq-section study-faq\u00bb][vc_column_inner][vc_column_text el_class=\u00bbfaq-heading\u00bb]<\/p>\n<h2 style=\"text-align: center;\">Preguntas frecuentes<\/h2>\n<p>[\/vc_column_text][vc_toggle title=\u00bb\u00bfCu\u00e1ntas personas participar\u00e1n en este estudio?\u00bb el_class=\u00bbfaq-data\u00bb]En el estudio sobre la epilepsia participar\u00e1n unas 250 personas.[\/vc_toggle][vc_toggle title=\u00bb\u00bfQu\u00e9 significan &quot;fase doble ciego&quot; y &quot;fase abierta&quot;?\u00bb el_class=\u00bbfaq-data\u00bb]\u00bbDoble ciego\u00bb significa que ni t\u00fa ni el m\u00e9dico del estudio sabr\u00e9is a qu\u00e9 grupo de tratamiento se te ha asignado en el estudio (es decir, si est\u00e1s recibiendo BHV-7000 o placebo).<br \/>\nUn placebo es una \u00abp\u00edldora ficticia\u00bb que no contiene principios activos.<br \/>\n\u00abDe etiqueta abierta\u00bb significa que todo el mundo, incluido t\u00fa, sabr\u00e1 lo que est\u00e1s recibiendo.<br \/>\nEn la fase abierta de este estudio, todos reciben BHV-7000; ning\u00fan participante de la fase abierta recibe placebo.[\/vc_toggle][vc_toggle title=\u00bb\u00bfCu\u00e1nto durar\u00e1 el estudio?\u00bb el_class=\u00bbfaq-data\u00bb]Tras un periodo de selecci\u00f3n de unos 30 d\u00edas, estar\u00e1s en la fase de tratamiento doble ciego durante un m\u00e1ximo de 24 semanas (hasta 7 visitas).<br \/>\nEs posible que puedas interrumpir esta fase antes de las 24 semanas, dependiendo de tu actividad convulsiva.<br \/>\nTras la fase doble ciego, puedes optar a la fase abierta del estudio para seguir recibiendo la medicaci\u00f3n del estudio durante 48 semanas (8 visitas).[\/vc_toggle][vc_toggle title=\u00bb\u00bfQu\u00e9 cl\u00ednicas participan en este estudio?\u00bb el_class=\u00bbfaq-data\u00bb]Para ver la lista completa de cl\u00ednicas participantes, visita <a href=\"https:\/\/clinicaltrials.gov\/study\/NCT06425159?cond=Generalized%20Epilepsy&amp;term=biohaven&amp;rank=1\">ClinicalTrials.gov<\/a>.[\/vc_toggle][vc_toggle title=\u00bb\u00bfTendr\u00e9 que pagar algo para participar?\u00bb el_class=\u00bbfaq-data\u00bb]No.<br \/>\nSi re\u00fanes los requisitos y eres elegido para participar, recibir\u00e1s toda la atenci\u00f3n relacionada con el estudio, sin coste alguno para ti.<br \/>\nNo es necesario tener seguro, y puede haber una compensaci\u00f3n por la participaci\u00f3n.[\/vc_toggle][vc_toggle title=\u00bb\u00bfQu\u00e9 pasa si despu\u00e9s de unirme al estudio decido que ya no quiero participar?\u00bb el_class=\u00bbfaq-data\u00bb]Como todos los estudios cl\u00ednicos, tu participaci\u00f3n es totalmente voluntaria.<br \/>\nPuedes abandonar el estudio en cualquier momento.[\/vc_toggle][vc_toggle title=\u00bb\u00bfCu\u00e1les son los siguientes pasos?\u00bb el_class=\u00bbfaq-data\u00bb]Visita la p\u00e1gina <a href=\"https:\/\/www.biohavenclinicaltrials.com\/es\/study-resources\/epilepsy-study-learn-more\/\">Ver si cumples los requisitos<\/a> para encontrar la cl\u00ednica m\u00e1s cercana.[\/vc_toggle][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row wrap_container=\u00bbyes\u00bb el_class=\u00bbfooter-button-row\u00bb conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb][vc_column el_class=\u00bbfooter-btn-row-col\u00bb conditional_render=\u00bb%5B%7B%22value_role%22%3A%22administrator%22%7D%5D\u00bb][vc_btn title=\u00bbMedicaci\u00f3n del estudio\u00bb align=\u00bbright\u00bb i_align=\u00bbright\u00bb i_icon_fontawesome=\u00bbfas fa-arrow-right\u00bb hover_effect=\u00bbhover-icon-right\u00bb add_icon=\u00bbtrue\u00bb el_class=\u00bbfooter-next-page-button\u00bb link=\u00bburl:https%3A%2F%2Fwww.biohavenclinicaltrials.com%2Fes%2Fstudy-resources%2Fepilepsy-study-medication%2F|title:Medicaci%C3%B3n%20del%20Estudio%20Shine|\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][vc_raw_html]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[\/vc_raw_html][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"featured_media":2465,"menu_order":0,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-2807","clinical-studies","type-clinical-studies","status-publish","format-standard","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Estudio sobre la epilepsia generalizada - Shine | Biohaven<\/title>\n<meta name=\"description\" content=\"Shine es un estudio para evaluar la eficacia, seguridad y tolerabilidad de BHV-7000 en pacientes con epilepsia generalizada idiop\u00e1tica. M\u00e1s informaci\u00f3n.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estudio sobre la epilepsia generalizada - Shine | Biohaven\" \/>\n<meta property=\"og:description\" content=\"Shine es un estudio para evaluar la eficacia, seguridad y tolerabilidad de BHV-7000 en pacientes con epilepsia generalizada idiop\u00e1tica. M\u00e1s informaci\u00f3n.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/\" \/>\n<meta property=\"og:site_name\" content=\"Biohaven Clinical Trials\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-11T13:36:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biohavenclinicaltrials.com\/wp-content\/uploads\/2023\/09\/Epilepsy-study-thumbnail.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.biohavenclinicaltrials.com\/wp-content\/uploads\/2023\/09\/Epilepsy-study-thumbnail.jpg\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/clinical-studies\\\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\\\/\",\"url\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/clinical-studies\\\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\\\/\",\"name\":\"Estudio sobre la epilepsia generalizada - Shine | Biohaven\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/clinical-studies\\\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/clinical-studies\\\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Epilepsy-Shine-Thumbnail.jpg\",\"datePublished\":\"2024-07-23T20:52:36+00:00\",\"dateModified\":\"2025-08-11T13:36:32+00:00\",\"description\":\"Shine es un estudio para evaluar la eficacia, seguridad y tolerabilidad de BHV-7000 en pacientes con epilepsia generalizada idiop\u00e1tica. M\u00e1s informaci\u00f3n.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/clinical-studies\\\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/clinical-studies\\\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/clinical-studies\\\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Epilepsy-Shine-Thumbnail.jpg\",\"contentUrl\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/Epilepsy-Shine-Thumbnail.jpg\",\"width\":447,\"height\":205,\"caption\":\"Girl looking at sunset at beach - epilepsy website\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/clinical-studies\\\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investigaci\u00f3n de una opci\u00f3n de tratamiento en fase de investigaci\u00f3n para la epilepsia generalizada idiop\u00e1tica\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/\",\"name\":\"Biohaven Clinical Trials\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.biohavenclinicaltrials.com\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Estudio sobre la epilepsia generalizada - Shine | Biohaven","description":"Shine es un estudio para evaluar la eficacia, seguridad y tolerabilidad de BHV-7000 en pacientes con epilepsia generalizada idiop\u00e1tica. M\u00e1s informaci\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/","og_locale":"es_ES","og_type":"article","og_title":"Estudio sobre la epilepsia generalizada - Shine | Biohaven","og_description":"Shine es un estudio para evaluar la eficacia, seguridad y tolerabilidad de BHV-7000 en pacientes con epilepsia generalizada idiop\u00e1tica. M\u00e1s informaci\u00f3n.","og_url":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/","og_site_name":"Biohaven Clinical Trials","article_modified_time":"2025-08-11T13:36:32+00:00","og_image":[{"url":"https:\/\/www.biohavenclinicaltrials.com\/wp-content\/uploads\/2023\/09\/Epilepsy-study-thumbnail.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_image":"https:\/\/www.biohavenclinicaltrials.com\/wp-content\/uploads\/2023\/09\/Epilepsy-study-thumbnail.jpg","twitter_misc":{"Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/","url":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/","name":"Estudio sobre la epilepsia generalizada - Shine | Biohaven","isPartOf":{"@id":"https:\/\/www.biohavenclinicaltrials.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/#primaryimage"},"image":{"@id":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biohavenclinicaltrials.com\/wp-content\/uploads\/2024\/07\/Epilepsy-Shine-Thumbnail.jpg","datePublished":"2024-07-23T20:52:36+00:00","dateModified":"2025-08-11T13:36:32+00:00","description":"Shine es un estudio para evaluar la eficacia, seguridad y tolerabilidad de BHV-7000 en pacientes con epilepsia generalizada idiop\u00e1tica. M\u00e1s informaci\u00f3n.","breadcrumb":{"@id":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/#primaryimage","url":"https:\/\/www.biohavenclinicaltrials.com\/wp-content\/uploads\/2024\/07\/Epilepsy-Shine-Thumbnail.jpg","contentUrl":"https:\/\/www.biohavenclinicaltrials.com\/wp-content\/uploads\/2024\/07\/Epilepsy-Shine-Thumbnail.jpg","width":447,"height":205,"caption":"Girl looking at sunset at beach - epilepsy website"},{"@type":"BreadcrumbList","@id":"https:\/\/www.biohavenclinicaltrials.com\/es\/clinical-studies\/researching-an-investigational-treatment-option-for-idiopathic-generalized-epilepsy\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biohavenclinicaltrials.com\/es\/"},{"@type":"ListItem","position":2,"name":"Investigaci\u00f3n de una opci\u00f3n de tratamiento en fase de investigaci\u00f3n para la epilepsia generalizada idiop\u00e1tica"}]},{"@type":"WebSite","@id":"https:\/\/www.biohavenclinicaltrials.com\/es\/#website","url":"https:\/\/www.biohavenclinicaltrials.com\/es\/","name":"Biohaven Clinical Trials","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biohavenclinicaltrials.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"_links":{"self":[{"href":"https:\/\/www.biohavenclinicaltrials.com\/es\/wp-json\/wp\/v2\/clinical-studies\/2807","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biohavenclinicaltrials.com\/es\/wp-json\/wp\/v2\/clinical-studies"}],"about":[{"href":"https:\/\/www.biohavenclinicaltrials.com\/es\/wp-json\/wp\/v2\/types\/clinical-studies"}],"version-history":[{"count":19,"href":"https:\/\/www.biohavenclinicaltrials.com\/es\/wp-json\/wp\/v2\/clinical-studies\/2807\/revisions"}],"predecessor-version":[{"id":3189,"href":"https:\/\/www.biohavenclinicaltrials.com\/es\/wp-json\/wp\/v2\/clinical-studies\/2807\/revisions\/3189"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biohavenclinicaltrials.com\/es\/wp-json\/wp\/v2\/media\/2465"}],"wp:attachment":[{"href":"https:\/\/www.biohavenclinicaltrials.com\/es\/wp-json\/wp\/v2\/media?parent=2807"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}